Product Center
Abundant achievements, showcasing technological hard power
- Categories:Company news
- Author:
- Origin:
- Time of issue:2022-12-15
- Views:
(Summary description)Recently, a press conference on the evaluation results of unicorn enterprises and gazelle enterprises in Jiangsu's high-tech zone was held in Nanjing. Ab&B Bio Tech CO., LTD. JS was identified as a po
Abundant achievements, showcasing technological hard power
(Summary description)Recently, a press conference on the evaluation results of unicorn enterprises and gazelle enterprises in Jiangsu's high-tech zone was held in Nanjing. Ab&B Bio Tech CO., LTD. JS was identified as a po
- Categories:Company news
- Author:
- Origin:
- Time of issue:2022-12-15 16:19
- Views:
Recently, a press conference on the evaluation results of unicorn enterprises and gazelle enterprises in Jiangsu's high-tech zone was held in Nanjing. Ab&B Bio Tech CO., LTD. JS was identified as a potential unicorn enterprise in Jiangsu Province.
Potential unicorn enterprises in Jiangsu Province are innovative enterprises with strong innovation capabilities, fast growth rates, and great development potential. They are a barometer of urban innovation vitality and industrial ecology, with high growth potential, strong innovation, and enormous potential. They are an important force leading industrial transformation in the new economic track. The recognition of potential unicorn enterprises in Jiangsu Province this time is a high recognition of the company's innovation and development level, and also a strong witness to the strength of Zhonghui Biotechnology's hard technology. Recently, the company's technological innovation and development have added fruitful results. The company's independently developed freeze-dried human rabies vaccine (human diploid cells) has made new progress and obtained the implied clinical trial license from the National Medical Products Administration. This variety has also become the fifth product of the company to enter the clinical stage, further enriching the company's product lineup and demonstrating the company's technological strength.
Relevant information
-
Ab&B Bio and Yither Bio have both obtained qualification certification!Recently, Ab&B Bio-Tech Co.,Ltd（Ab&B Bio） and its subsidiary Yither biotech (Shanghai) Co., Ltd (Yither Bio) have been recognized as Jiangsu Province's specialized and innovative small and medium-sized enterprises and national high-tech enterprises, respectively. - The kickoff meeting for clinical research on the immunogenicity and safety of quadrivalent influenza virus subunit vaccine for children with nephrotic syndrome was successfully held 12-25
- Influenza virus subunit vaccine (adjuvant) IND application approved 10-30
- The application for the marketing of trivalent influenza virus subunit vaccine has been accepted! 10-08
- Breaking through bottleneck technology, significant progress has been made in the research and development of new adjuvants 08-26
Have a project？Get a touch!
Caring for life, protecting health, and making global technological innovation vaccines are the mission of Ab&B Bio
Contact
E-mail:info@abbbio.com.cn
Add:No. 32, Xinglin Road, Medical High-tech Zone, Taizhou City
Quick view
Follow us
